Varta
← Back to stories

From NDTV

Center-Right Owned by Adani Group (AMG Media)

Novo Nordisk Loses US Ruling Over Eli Lilly Obesity Drug Ads

Novo Nordisk Loses US Ruling Over Eli Lilly Obesity Drug Ads

RSS excerpt

According to the Novo complaint, Lilly ads say people on Zepbound lost an average of 50 pounds, while Wegovy users lost an average of 33 pounds.

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →